Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H32N8O2 |
Molecular Weight | 512.6061 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCN(CC1)C2=CC=C(NC3=NC=C4C(=O)N5CC=CCC[C@@](C)(O)C6=NC(=CC=C6)N5C4=N3)C=C2
InChI
InChIKey=KSZKLDQYICQTLL-WHQCRVIKSA-N
InChI=1S/C28H32N8O2/c1-28(38)13-4-3-5-14-35-26(37)22-19-29-27(32-25(22)36(35)24-8-6-7-23(28)31-24)30-20-9-11-21(12-10-20)34-17-15-33(2)16-18-34/h3,5-12,19,38H,4,13-18H2,1-2H3,(H,29,30,32)/b5-3-/t28-/m1/s1
Molecular Formula | C28H32N8O2 |
Molecular Weight | 512.6061 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:33:44 GMT 2023
by
admin
on
Sat Dec 16 19:33:44 GMT 2023
|
Record UNII |
HRE3327KCX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
HRE3327KCX
Created by
admin on Sat Dec 16 19:33:44 GMT 2023 , Edited by admin on Sat Dec 16 19:33:44 GMT 2023
|
PRIMARY | |||
|
155132201
Created by
admin on Sat Dec 16 19:33:44 GMT 2023 , Edited by admin on Sat Dec 16 19:33:44 GMT 2023
|
PRIMARY | |||
|
2510782-14-4
Created by
admin on Sat Dec 16 19:33:44 GMT 2023 , Edited by admin on Sat Dec 16 19:33:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
PRECLINICAL
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|